Loading…
for educational and safety purposes
Pramiracetam and Aniracetam both come up in the same conversations; they overlap on Acetylcholine. Pramiracetam: Pramiracetam is a laboratory-made compound in the piracetam ("racetam") family, developed by Parke-Davis as CI-879 and later sold in a few European countries as a prescription memory drug under the brand name Pramistar. Aniracetam: Aniracetam is a fat-soluble member of the racetam family and one of the original ampakines, a positive allosteric modulator of AMPA-type glutamate receptors used as a cognition enhancer.
Pramiracetam is a laboratory-made compound in the piracetam ("racetam") family, developed by Parke-Davis as CI-879 and later sold in a few European countries as a prescription memory drug under the brand name Pramistar. It is meant to improve memory and attention; in animals it reliably increases the rate at which brain cells take up choline, a building block of the memory-related signalling chemical acetylcholine, but no receptor that it binds to has ever been identified. Human evidence is thin: a small placebo-controlled trial in men with head injuries reported better delayed recall, and a study in healthy volunteers found it partly blunted drug-induced forgetting, while a trial in Alzheimer's disease found no benefit even at high doses. The entire published literature is roughly 40 papers, most of them small, decades old, or done in rodents, so confident claims that it strongly enhances cognition in healthy people are not supported by what has actually been measured.
Aniracetam is a fat-soluble member of the racetam family and one of the original ampakines, a positive allosteric modulator of AMPA-type glutamate receptors used as a cognition enhancer. By slowing the desensitization of these excitatory receptors it strengthens the synaptic transmission tied to learning and memory, and it has been used clinically abroad for cognitive symptoms after stroke and in dementia. Its principal metabolite, 2-pyrrolidinone, has been reported to produce a longer-lasting enhancement of AMPA-receptor function through a CaMKII-dependent pathway. It is also noted for anxiolytic and mood effects in animal models.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
enhances
Permissive requirement, not a direct target; memory effect is abolished without intact steroid signalling
raises
Normalises scopolamine-induced changes in choline permeability; increases cerebral blood flow
No measurable affinity
Increases enzyme activity without changing NOS mRNA
Inhibitor
Increases choline uptake; bell-shaped dose-response
Antiaggregant, reported as mediated mainly via inhibition of thromboxane A2 metabolism
modulates
positive modulator
increases
mild agonist
modulates
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.
easiest to source: Aniracetam is currently listed by more trusted vendors (2), so it's the simpler one to get hold of. for effects and safety, read each full entry; this is educational, not medical advice.